Pharmacy
If the current pandemic continues much longer, acquiring needed ventilator medications will present long-term challenges for patient care.
Should states win their case to regulate how PBMs contract with pharmacies, plan costs will rise, AHIP says.
Some of the medications being used to treat COVID-19 are known to increase cardiac risk in some people.
The recommendations center on redirecting the supply of the drugs from retail pharmacy settings to the hospital/acute care environment.
Because there's such a high level of uncertainty, the risk of a more severe economic impact is elevated and expenses will rise.
Optum Ventures is among companies investing $25 million, betting on the company's ability to show for which patients Humira doesn't work.
The savings are due in part to strict price-reporting controls on pharmaceutical companies and the continuance of drug manufacturer rebates.
Inflation-adjusted list prices increased by 159% from 2007 to 2018, while net prices increased 60%.
The formulary includes about 100 drugs, including insulin, and is expected to expand.
World Health Organization says it hopes to have a candidate vaccine in 16 weeks.